ACAD Stock-Based Compensation
Acadia Pharmaceuticals Inc · Stock-Based Compensation
ACAD Stock-Based Compensation
Latest reported$59.52Mperiod ending
ACAD Stock-Based Comp ($0.00 → $59.52M)
Annual stock-based compensation
High-resolution chart · PNG
ACAD stock-based compensation history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 0 | |
| 67,049,000 | |
| 66,421,000 | |
| 68,201,000 | |
| 63,615,000 | |
| 84,422,000 | |
| 82,265,000 | |
| 81,564,000 | |
| 75,532,000 | |
| 55,265,000 | |
| 40,194,000 | |
| 16,039,000 | |
| 5,711,000 | |
| 1,930,000 | |
| 1,598,000 | |
| 1,583,000 | |
| 2,134,000 | |
| 2,987,000 | |
| 3,378,000 | |
| 3,378,000 | |
| 1,307,700,000 | |
| 2,355,800,000 | |
| 0 | |
| 0 | |
| 0 |